APA (7th ed.) Citation

Meulendijks, D., van Hasselt, J. C., Huitema, A. D., van Tinteren, H., Deenen, M. J., Beijnen, J. H., . . . Schellens, J. H. (2016). Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care. European journal of cancer (1990), 54, 120-130. https://doi.org/10.1016/j.ejca.2015.10.013

Chicago Style (17th ed.) Citation

Meulendijks, Didier, J.G. Coen van Hasselt, Alwin D.R Huitema, Harm van Tinteren, Maarten J. Deenen, Jos H. Beijnen, Annemieke Cats, and Jan H.M Schellens. "Renal Function, Body Surface Area, and Age Are Associated with Risk of Early-onset Fluoropyrimidine-associated Toxicity in Patients Treated with Capecitabine-based Anticancer Regimens in Daily Clinical Care." European Journal of Cancer (1990) 54 (2016): 120-130. https://doi.org/10.1016/j.ejca.2015.10.013.

MLA (9th ed.) Citation

Meulendijks, Didier, et al. "Renal Function, Body Surface Area, and Age Are Associated with Risk of Early-onset Fluoropyrimidine-associated Toxicity in Patients Treated with Capecitabine-based Anticancer Regimens in Daily Clinical Care." European Journal of Cancer (1990), vol. 54, 2016, pp. 120-130, https://doi.org/10.1016/j.ejca.2015.10.013.